1. Home
  2. CLB vs EOLS Comparison

CLB vs EOLS Comparison

Compare CLB & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLB
  • EOLS
  • Stock Information
  • Founded
  • CLB 1936
  • EOLS 2012
  • Country
  • CLB United States
  • EOLS United States
  • Employees
  • CLB N/A
  • EOLS N/A
  • Industry
  • CLB
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLB
  • EOLS Health Care
  • Exchange
  • CLB Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • CLB 482.5M
  • EOLS 412.0M
  • IPO Year
  • CLB 1995
  • EOLS 2018
  • Fundamental
  • Price
  • CLB $11.16
  • EOLS $7.68
  • Analyst Decision
  • CLB Hold
  • EOLS Strong Buy
  • Analyst Count
  • CLB 2
  • EOLS 5
  • Target Price
  • CLB $12.50
  • EOLS $21.25
  • AVG Volume (30 Days)
  • CLB 450.4K
  • EOLS 2.3M
  • Earning Date
  • CLB 07-23-2025
  • EOLS 08-05-2025
  • Dividend Yield
  • CLB 0.36%
  • EOLS N/A
  • EPS Growth
  • CLB 23.99
  • EOLS N/A
  • EPS
  • CLB 0.62
  • EOLS N/A
  • Revenue
  • CLB $517,378,000.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • CLB N/A
  • EOLS $33.42
  • Revenue Next Year
  • CLB $2.24
  • EOLS $33.18
  • P/E Ratio
  • CLB $17.96
  • EOLS N/A
  • Revenue Growth
  • CLB 0.70
  • EOLS 17.15
  • 52 Week Low
  • CLB $9.72
  • EOLS $5.71
  • 52 Week High
  • CLB $21.83
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • CLB 52.96
  • EOLS 48.97
  • Support Level
  • CLB $10.15
  • EOLS $6.21
  • Resistance Level
  • CLB $10.72
  • EOLS $6.94
  • Average True Range (ATR)
  • CLB 0.45
  • EOLS 0.43
  • MACD
  • CLB 0.09
  • EOLS 0.14
  • Stochastic Oscillator
  • CLB 97.30
  • EOLS 57.27

About CLB Core Laboratories Inc.

Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: